The UK Competition and Markets Authority or CMA has approved AstraZeneca Plc.'s (AZN.L,AZN) proposed acquisition of Alexion Pharmaceuticals Inc. (ALXN). The acquisition is expected to close on 21 July 2021.
AstraZeneca noted that a group focusing on rare diseases will be created. The group will be named 'Alexion, AstraZeneca Rare Disease', and will be headquartered in Boston, US.
Last week, AstraZeneca said it received clearance from the European Commission for the proposed acquisition of Alexion Pharmaceuticals. The clearance followed competition clearances in the United States, Japan and other countries globally.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.